Anagenex Closes $30 Million Series A Round Led By Catalio To Advance Small Molecule Drug Discovery With A Novel, Directed Evolution Platform
Amount Raised
$30 Million
Round Type
Series A
LexingtonMedia And EntertainmentHealth CareScience And EngineeringDescription
Anagenex, a pioneering drug discovery company pairing large-scale data generation with machine learning to discover the next generation of small molecule medicines, today announced that it has closed a $30 million Series A financing round led by Catalio Capital Management, with participation from existing investors Lux Capital, Khosla Ventures, Obvious Ventures, Air Street Capital, and Menlo Ventures. Catalio’s George Petrocheilos and Dr. Matthew Hobson will be joining the company’s Board as a Director and Observer respectively. Anagenex will use its Series A funds to further expand its novel data generating platform and build a robust pipeline of programs addressing historically challenging unmet medical needs.
Quick answer
Anagenex raised $30 Million in a Series A round, dated June 8, 2022. Anagenex is based in Lexington, Massachusetts, United States.
- How much did Anagenex raise?
- Anagenex raised $30 Million in a Series A round on June 8, 2022.
- What does Anagenex do?
- Anagenex is a pre-clinical biotechnology innovator advancing drug discovery through its small molecule directed evolution platform.
- Where is Anagenex based and how big is it?
- Anagenex is based in Lexington, Massachusetts, United States.
- Who are the decision-makers at Anagenex?
- Fundz holds 1 contact at Anagenex. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Media And Entertainment and Science And Engineering around the same time
Companies in the same sectors as Anagenex that raised within 45 days of this round, from Fundz verified event records.
- 22nd Century raised $35M on July 21, 2022.
- 22nd Century raised $58M on May 25, 2022.
- Trait Biosciences Inc. raised $102K (Series A) on July 22, 2022.
- Enveric Biosciences raised $8.6M on July 22, 2022.
- Camp4 Therapeutics Corp raised $100M (Series B) on July 20, 2022.
- Oncoshot raised an undisclosed amount (Funding Round) on July 14, 2022.
Who to call at Anagenex, and when
A new round usually means Anagenex is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Anagenex raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Anagenex, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Anagenex. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Anagenex raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAnagenex raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.